349 related articles for article (PubMed ID: 27631233)
1. HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.
Wen J; Xie K; Zhang M; Chen J; Zhang J; Cheng D; Li X; Ji S; Liu Z
Medicine (Baltimore); 2016 Sep; 95(37):e4809. PubMed ID: 27631233
[TBL] [Abstract][Full Text] [Related]
2. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Wang C; Lu H; Yang C; Luo Y
Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263
[TBL] [Abstract][Full Text] [Related]
3. Membranous nephropathy: recent travels and new roads ahead.
Beck LH; Salant DJ
Kidney Int; 2010 May; 77(9):765-70. PubMed ID: 20182413
[TBL] [Abstract][Full Text] [Related]
4. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
5. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
[TBL] [Abstract][Full Text] [Related]
6. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
8. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
[TBL] [Abstract][Full Text] [Related]
9. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.
Xu NX; Xie QH; Sun ZX; Wang J; Li Y; Wang L; Liu SJ; Xue J; Hao CM
Chin Med J (Engl); 2017 Apr; 130(8):892-898. PubMed ID: 28397717
[TBL] [Abstract][Full Text] [Related]
10. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
[TBL] [Abstract][Full Text] [Related]
11. M-type phospholipase A
Kanda S; Horita S; Yanagihara T; Shimizu A; Hattori M
Pediatr Nephrol; 2017 Apr; 32(4):713-717. PubMed ID: 27921164
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
[TBL] [Abstract][Full Text] [Related]
13. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
[TBL] [Abstract][Full Text] [Related]
14. Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen.
Škoberne A; Behnert A; Teng B; Fritzler MJ; Schiffer L; Pajek J; Lindič J; Haller H; Schiffer M
Eur J Clin Invest; 2014 Aug; 44(8):753-65. PubMed ID: 24942189
[TBL] [Abstract][Full Text] [Related]
15. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.
Lv J; Hou W; Zhou X; Liu G; Zhou F; Zhao N; Hou P; Zhao M; Zhang H
J Am Soc Nephrol; 2013 Jul; 24(8):1323-9. PubMed ID: 23813219
[TBL] [Abstract][Full Text] [Related]
16. MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor.
Liu D; Liu F; Wang X; Qiao Y; Pan S; Yang Y; Hu Y; Zhang Y; Tian F; Liu Z
Cell Cycle; 2018; 17(21-22):2484-2495. PubMed ID: 30394845
[TBL] [Abstract][Full Text] [Related]
17. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T
PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365
[TBL] [Abstract][Full Text] [Related]
18. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
Hill PA; McRae JL; Dwyer KM
Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
[TBL] [Abstract][Full Text] [Related]
19. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
[TBL] [Abstract][Full Text] [Related]
20. Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy.
Mella A; Deambrosis I; Mingozzi S; Colla L; Burdese M; Giaretta F; Bruno S; Camussi G; Boaglio E; Dolla C; Clari R; Biancone L
Sci Rep; 2020 Oct; 10(1):16362. PubMed ID: 33004982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
